Effect of Hypnosis Combined to Transcranial Direct Stimulation in Pain

November 22, 2018 updated by: Wolnei Caumo, Hospital de Clinicas de Porto Alegre

Effect of Hypnosis Combined to Transcranial Direct Stimulation in Cortical Activity and Pain Perception in Healthy Females

Pain is a public health condition, which causes great functional disability. Its consequences pervade the personal and social life of the patient, leading to significant changes in their interpersonal relationships, including work, family and social spheres, reducing the ability to perform daily activities. Conventional treatment modalities have been show a very poor therapeutic response, in that most individuals end up becoming polymedicated patients and refractory to treatment. Among non-pharmacological techniques with promising analgesic effects it includes both the hypnotic analgesia and the transcranial stimulation of direct current (tDCS).

Study Overview

Detailed Description

Introduction: Pain is a public health condition, which causes great functional disability. Its consequences pervade the personal and social life of the patient, leading to significant changes in their interpersonal relationships, including work, family and social spheres, reducing the ability to perform daily activities. Conventional treatment modalities have been show a very poor therapeutic response, in that most individuals end up becoming polymedicated patients and refractory to treatment. Among non-pharmacological techniques with promising analgesic effects it includes both the hypnotic analgesia and the transcranial stimulation of direct current (tDCS). Objective: To evaluate the synergistic effect of hypnotic analgesia associated with tDCS under metabolites parameters and pain levels in healthy individuals before a nociceptive stimulation pattern. Methods: it will be performed a blinded crossover sham controlled randomized clinical trial. It will be included 32 woman healthy subjects, Susceptible to the hypnosis technique according to the Scale of Hypnotic Susceptibility (WSGC) Scale of Hypnotic Scale score. aged 18 to 65. They will be allocated in one of the following groups: active tDCS + hypnotic analgesia, sham tDCS + hypnotic analgesia, hypnotic analgesia and tDCS . After a 7 days interval, the groups will be crossed in order to receive the opposite intervention of the first week. The primary endpoints will be the electrophysiological brain parameters, such as changes in the Theta, Alpha and Gamma waves, as measured by EEG. The secondary endpoints will be the level of pain, measured against nociceptive induced by the cold test and stimuli standardized pressure through algometry pressure and power down system modulatory pain, pain using the subject test - CPM - task. The intra and inter-group comparisons will be made by means of two-way ANOVA followed by Bonferroni. A p significance level of <0.05 was established. Expected results: This study hypothesizes that a synergistic effect of analgesic techniques in pain levels in healthy subjects compared to isolated character.

Study Type

Interventional

Enrollment (Actual)

48

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Rio Grande Do Sul
      • Porto Alegre, Rio Grande Do Sul, Brazil, 90.450-120
        • Hospital de Clínicas de Porto Alegre
      • Porto Alegre, Rio Grande Do Sul, Brazil, 90035-003
        • Hospital de Clinicas e Porto Alegre (HCPA)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Healthy
  • Female
  • 11 years of schooling
  • 12 cut-off at Waterloo-Stanford Group C (WSGC)

Exclusion Criteria:

  • hearing loss subjects
  • formal contraindication to tDCS (pregnancy, deep brain device, epilepsy, seizure)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Hypnotic analgesia

Intervention:

- Subjects will receive hypnotic analgesia

Subjects will receive hypnotic analgesia during 20 minutes
Experimental: a-tDCS

Intervention: transcranial direct current stimulation - tDCS

  • active tDCS stimulation
  • montage: bilateral DLPFC anodal/left and cathodal/right
  • current:2 milliamps
  • time: 20 minutes
Subjects will receive hypnotic analgesia during 20 minutes
Subjects will receive sham transcranial direct stimulation over bilateral DLPFC left/anode right/cathodal, 0mA, 20 minutes
Sham Comparator: s-tDCS

Sham comparator: transcranial direct current stimulation - tDCS

  • sham tDCS stimulation
  • montage: bilateral DLPFC anodal/left and cathodal/right
  • current: 0 milliamps
  • time: 20 minutes
Subjects will receive transcranial direct stimulation over bilateral DLPFC left/anode right/cathodal, 2mA, 20 minutes
Subjects will receive hypnotic analgesia associated to transcranial direct stimulation over bilateral DLPFC left/anode right/cathodal, 2mA, 20 minutes
Experimental: Hypnotic analgesia + a-tDCS

Intervention:

  • hypnotic analgesia
  • active tDCS stimulation
  • montage: bilateral DLPFC anodal/left and cathodal/right
  • current:2 milliamps
  • time: 20 minutes
Subjects will receive hypnotic analgesia associated to transcranial direct stimulation over bilateral DLPFC left/anode right/cathodal, 2mA, 20 minutes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Alpha waves
Time Frame: 60 minutes
Variations in the alpha waves power from post to pre-intervention using electroencephalography during a cold pressor test
60 minutes
Change in Theta waves
Time Frame: 60 minutes
Variations in the theta waves power from post to pre-intervention using electroencephalography during a cold pressor test
60 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in beta waves
Time Frame: 60 minutes
Variations in the beta waves power from post to pre-intervention using electroencephalography during a cold pressor test
60 minutes
Change in gamma waves
Time Frame: 60 minutes
Variations in the gamma waves power from post to pre-intervention using electroencephalography during a cold pressor test
60 minutes
Change in delta waves
Time Frame: 60 minutes
Variations in the delta waves power from post to pre-intervention using electroencephalography during a cold pressor test
60 minutes
Change in Heat thermal threshold
Time Frame: 60 minutes
The measure will be assessed by Quantitative Sensorial Test - QST, in which a thermode delivers a heat stimulus of increasing magnitude. Heat thermal threshold (HTT) is the averaged temperature for 3 stimuli where participant indicates the first heat sensation.
60 minutes
Change in Heat pain threshold
Time Frame: 60 minutes
The measure will be assessed by Quantitative Sensorial Test - QST, in which a thermode delivers a heat stimulus of increasing magnitude. Heat pain threshold (HPT) is the averaged temperature for 3 stimuli where participant indicates the first heat pain sensation.
60 minutes
Change in Heat pain tolerance
Time Frame: 60 minutes
The measure will be assessed by Quantitative Sensorial Test - QST, in which a thermode delivers a heat stimulus of increasing magnitude. Heat pain tolerance (HPTo) is the temperature for the stimulus where participant indicates the maximum pain tolerance.
60 minutes
Change in Numeric pain scale during CPM task
Time Frame: 60 minutes
The measure will be assessed by the conditioned pain modulation (CPM) task in which an ice cold water (0 a 1 degrees Celsius) is the conditioning stimulus presented to the left hand and a moderate heat pain stimulus from the QST to the contralateral hand. The measure consists of the response using a numeric pain scale (0 - 10) for the heat pain stimulus during the CPM task.
60 minutes
Change in Cold Pressor Test 0 to 1 degree Celsius - time
Time Frame: 60 minutes
Participant puts his right hand in an ice cold water (0 a 1 degrees Celsius). Measure consists of the time (in seconds) the participant keeps his hand in the water the maximum he could tolerance.
60 minutes
Change in Cold Pressor Test 10 degree Celsius - time
Time Frame: 60 minutes
Participant puts his right hand in an ice cold water (10 degrees Celsius). Measure consists of the time (in seconds) the participant keeps his hand in the water the maximum he could tolerate.
60 minutes
Change in Cold Pressor Test 10 degree Celsius - pain
Time Frame: 60 minutes
Participant puts his right hand in an ice cold water (10 degrees Celsius). Measure consists of the response to a numeric pain scale (0 to 10) to the pain sensation when the participant withdraw his hand from the water.
60 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Wolnei Caumo, MD. PhD, Federal University of Rio Grande do Sul

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 18, 2017

Primary Completion (Actual)

November 1, 2018

Study Completion (Actual)

November 1, 2018

Study Registration Dates

First Submitted

September 21, 2017

First Submitted That Met QC Criteria

November 14, 2018

First Posted (Actual)

November 19, 2018

Study Record Updates

Last Update Posted (Actual)

November 26, 2018

Last Update Submitted That Met QC Criteria

November 22, 2018

Last Verified

November 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain Acute

Clinical Trials on Hypnotic analgesia

Subscribe